Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference32 articles.
1. Inflammatory bowel disease - one entity with many molecular faces;Szymańska;Prz Gastroenterol,2019
2. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study;Cleynen;Lancet,2016
3. Progress with infliximab biosimilars for inflammatory bowel disease;Kurti;Expert Opin Biol Ther,2018
4. ECCO guidelines on therapeutics in Crohn's disease: medical treatment;Torres;J Crohns Colitis,2019
5. ACG clinical guideline: ulcerative colitis in adults;Rubin;Am J Gastroenterol,2019
Cited by 126 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical experience of using biosimilars in Crohn’s disease and their effectiveness;Expert Opinion on Biological Therapy;2024-09-13
2. Infliximab in Inflammatory Bowel Disease: Leveraging Physiologically Based Pharmacokinetic Modeling in the Clinical Context;Biomedicines;2024-09-01
3. Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-Tumor Necrosis Factors;The Korean Journal of Gastroenterology;2024-08-25
4. Subcutaneous Infliximab Cutoff Points in Patients With Inflammatory Bowel Disease: Data From the ENEIDA Registry;Journal of Crohn's and Colitis;2024-08-22
5. Current Treatments, Emerging Therapeutics, and Natural Remedies for Inflammatory Bowel Disease;Molecules;2024-08-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3